Encompass Health (AMEX:EHC) is scheduled to be releasing its earnings data after the market closes on Monday, February 19th. Analysts expect Encompass Health to post earnings of $0.64 per share for the quarter.
Encompass Health (AMEX EHC) opened at $51.35 on Monday. The firm has a market capitalization of $5,040.00, a P/E ratio of 18.74, a P/E/G ratio of 1.70 and a beta of 0.49. Encompass Health has a 52-week low of $40.14 and a 52-week high of $54.13. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34.
Several research analysts have recently commented on EHC shares. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $52.00 price target for the company in a research report on Monday, October 30th. Mizuho upgraded Encompass Health from a “neutral” rating to a “buy” rating and set a $55.00 price target on the stock in a research note on Thursday, November 2nd. Royal Bank of Canada restated a “buy” rating on shares of Encompass Health in a research note on Wednesday, November 15th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Tuesday, November 21st. Finally, SunTrust Banks set a $58.00 price target on Encompass Health and gave the company a “buy” rating in a research note on Thursday, December 21st. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the stock. Encompass Health currently has a consensus rating of “Hold” and an average target price of $54.55.
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.